Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to traumatic choroidal rupture

Eye

Volumn 23, Issue 11, 2009, Pages 2125-2126

  Chanana, Bhuvan ^a   Azad, R V ^a   Kumar, N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; BLUNT TRAUMA; CASE REPORT; CHOROID RUPTURE; EYE INJURY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LETTER; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; RETINA EDEMA; RETINA HEMORRHAGE; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROID; CHOROIDAL NEOVASCULARIZATION; CRANIOCEREBRAL TRAUMA; FEMALE; HEAD INJURIES, CLOSED; HUMANS; INTRAVITREAL INJECTIONS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 68549113406     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.434     Document Type: Letter

References (5)

1. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006; 113: 363-372.
2. Arias L, Planas N, Prades S, Caminal JM, Rubio M, Pujol O et al. Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results. Br J Ophthalmol 2008; 92: 1035-1039.
3. Apte RS. Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to angioid streaks. Eye 2008; 22: 734-735.
4. Secrétan M, Sickenberg M, Zografos L, Piguet B. Morphometric characteristics of traumatic choroidal ruptures associated with neovascularization. Retina 1998; 18: 62-66.
5. Conrath J, Forzano O, Ridings B. Photodynamic therapy for subfoveal CNV complicating traumatic choroidal rupture. Eye 2004; 18: 946-947.